Wainzua

Medicinal product

(Invented) name

Wainzua

Active substance (s)

Eplontersenas

Strength

45 mg

Pharmaceutical form

injekcinis tirpalas užpildytame švirkštiklyje

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N07XX21, eplontersen

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

2025-03-06

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Užpildytame švirkštiklyje (0,8 ml tirpalo) yra	0.8 ml
Eplontersenas	45 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116914	103018	1103018	užpildytas švirkštiklis	0,8 ml N1		Receptinis	EU/1/24/1875/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-03-06	Registruotas